Clinical trial
Influence of Genes on Sirolimus Metabolism in Patients With Kidney…
NCT00352547 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00352547 |
|---|---|
| Title | Influence of Genes on Sirolimus Metabolism in Patients With Kidney Transplantation |
| Official title | Influence of MDR-1 CYP3A4 and CYP3A5 Genotypes/Haplotypes on Sirolimus Pharmacokinetics and Pharmacodynamics in Patients With Renal Transplantation |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Renal Transplant |
| Enrollment | 93 |
| Start date | May 21, 2004 |
| Completion | Dec 2, 2013 |
| First posted | Jul 14, 2006 |
| Last update posted | Oct 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: